{
    "code": 0,
    "data": [
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please refer to the attachment.",
            "news_id": "aa2aa5a5-e976-4b26-b55c-85e207805ef6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd6da361-2bce-497d-936b-de6a8697c8fb.pdf",
            "news_date": "2026-02-05 17:51:54",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For The Quarter And Nine Months Ended 31.12.2025",
            "news_body": "Please refer to the attachment.",
            "news_id": "eb321d8a-9f8e-4183-bb49-33307ef7e905",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ca23e6a-1504-4cce-965a-0fe8dc1c1352.pdf",
            "news_date": "2026-02-05 17:07:53",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter ended 30.09.2025",
            "news_id": "6e9013b8-89f9-41d9-b814-2082d449f47f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db6134ec-e213-4991-8912-9b4eca8a2d39.pdf",
            "news_date": "2025-11-10 18:55:42",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Please refer to the attachment.",
            "news_id": "976c43cb-6c27-44f1-b256-9b97cffa6abb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=402f8213-9a7e-4c47-8495-e0ac6a3d283e.pdf",
            "news_date": "2025-11-10 16:18:50",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please refer to the attachment",
            "news_id": "fc0f6437-d03f-4654-a733-db771953a99c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1776c04-b5dc-4d66-a742-07c82bd921e5.pdf",
            "news_date": "2025-08-01 20:20:16",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended 30Th June 2025.",
            "news_body": "Please refer to the attachment.",
            "news_id": "cbc00b2b-e583-4cc0-9441-08fea56618aa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=242f98a4-f681-464c-9db5-ceaf8ce5607f.pdf",
            "news_date": "2025-08-01 14:45:48",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please refer attached annexure for detailed information",
            "news_id": "4c4eabb9-532e-400c-aba7-863441ec0f0d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c7c83f0-8bfb-4fee-9214-6ef1b41a49cd.pdf",
            "news_date": "2025-05-20 22:26:24",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31St March 2025",
            "news_body": "Please refer attached annexure for further information",
            "news_id": "52817ba0-9a71-4ba9-b9b4-f96bf55c0eb1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b470e68-dd9b-4d36-a14d-c73784157aae.pdf",
            "news_date": "2025-05-20 20:36:59",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please refer to the attached Investor presentation for detailed information.",
            "news_id": "8ef1889e-4f1c-4c16-b3c1-eb182d268083",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=712afa55-f8c7-4e97-aaaf-ab72e4c35420.pdf",
            "news_date": "2025-02-14 20:05:10",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For The Quarter And Nine Months Ended 31.12.2024",
            "news_body": "Please refer to the attachment.",
            "news_id": "713bb092-73dc-47a8-99e0-538a49177f85",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98a23f89-c78f-4467-951c-345fdc5daff5.pdf",
            "news_date": "2025-02-14 13:17:06",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please refer to the attachment.",
            "news_id": "a87adfd1-2f9c-4d3e-8d79-64177039f8a8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2585f02-e883-4c11-ae50-40f8e2c8cee3.pdf",
            "news_date": "2024-10-25 20:21:38",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results: Financial Results For The Quarter And Half Year Ended 30Th September, 2024",
            "news_body": "Please refer to the attachment.",
            "news_id": "34cccb07-5cdf-4719-9194-6c9cec2defc1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d842b02-08db-42b2-89a3-093efc69e8ff.pdf",
            "news_date": "2024-10-25 13:32:47",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "As per the attached file.",
            "news_id": "dc5cd5e3-646a-43f0-970e-587944412c18",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb27c040-921a-40b3-941d-18ff1efc389b.pdf",
            "news_date": "2024-07-27 10:32:29",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For The Quarter Ended 30Th June, 2024.",
            "news_body": "Please refer to the attachment.",
            "news_id": "4d5caca6-908f-4cad-a97e-496fec76a839",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73902fae-bbca-49f7-955e-137171712c5c.pdf",
            "news_date": "2024-07-26 14:29:12",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Kindly refer to the attached file.",
            "news_id": "ed6ff1d5-cdab-4192-9d93-252b5bed68de",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29e2e72f-c184-490c-96be-a9c3464e3170.pdf",
            "news_date": "2024-05-16 10:59:29",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Year Ended 31 March 2024.",
            "news_body": "Please find our intimation on the captioned subject.",
            "news_id": "ce500164-a138-4bee-a473-4f08c69be489",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb1beeb7-ca83-4626-822f-e23493d3ce25.pdf",
            "news_date": "2024-05-14 15:18:25",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please refer Investors'' Presentation for the quarter ended 31st December, 2023",
            "news_id": "e4256dd3-6cef-427c-98bb-640c3f8df311",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4574643a-08ef-48f2-b4f9-5ef203204ab8.pdf",
            "news_date": "2024-02-10 16:30:45",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31St December, 2023",
            "news_body": "Please refer the attachment",
            "news_id": "11ae9353-d4ca-462e-8a3e-aabe6d707335",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5f394b3-7919-4cd5-8934-caf630cce166.pdf",
            "news_date": "2024-02-10 11:09:34",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find our intimation on the captioned matter",
            "news_id": "69430496-1baa-4c51-948c-985d6966d931",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aaef3cb8-0870-4c3b-9e11-a79200235997.pdf",
            "news_date": "2023-11-10 10:22:15",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find our intimation on the captioned subject",
            "news_id": "dbafa884-230b-4a55-8c40-8cef6ebfb1cc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c775e70-5579-47b3-941a-c2245889783f.pdf",
            "news_date": "2023-11-04 16:03:02",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended 30Th September 2023",
            "news_body": "Please find financial results along with outcome of board meeting of the Company held on 4th November 2023",
            "news_id": "bcaf8e48-2215-43b3-b8a8-6d5bdbbf3659",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13f71fb9-5ca3-45c2-930c-7d602e18f312.pdf",
            "news_date": "2023-11-04 11:23:27",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In terms of Regulation 30 of the SEBI (LODR) Regulations, 2015, we hereby submit Investors'' Presentation with respect to business overview of the Company.",
            "news_id": "e50955f0-f8f2-4056-a303-666042cb8e44",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10641d04-087d-4705-aeb6-fbf3011a8268.pdf",
            "news_date": "2023-08-14 19:16:46",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Quarter Ended June 30, 2023",
            "news_body": "Please find attached a copy of unaudited financial results along with Limited Review Report for the quarter ended June 30, 2023.",
            "news_id": "4d775124-8c29-4819-b27e-4484018ffcff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=013ba818-8afd-4f48-9450-075156478d32.pdf",
            "news_date": "2023-08-10 10:58:27",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and with reference to our letter dated 8th May, 2023, intimating you about the earning conference call for Q4 & FY23 with Analysts/Investors held on 15th May, 2023, please find attached herewith the transcript of the aforesaid conference call.The above information is also available on the website of the Company at www.gtbl.in",
            "news_id": "0ca56035-fa30-48ae-be71-834afcaba479",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6dda6542-2d69-45a2-ad54-5f893c58a564.pdf",
            "news_date": "2023-05-19 15:04:40",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of The Earnings Conference Call For Q4 & FY23",
            "news_body": "Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that the audio recording of earnings conference call, conducted on Monday, May 15, 2023, for the quarter and year ended March 31, 2023, has been uploaded on the website of the Company at http://www.gtbl.in/wp-content/uploads/2023/05/Concall-dated-15.05.2023.mp3",
            "news_id": "1968bde3-0e48-4978-a630-c4c3753577fa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3de40cd4-1bfa-4a8f-8b67-1b841d998825.pdf",
            "news_date": "2023-05-15 13:42:38",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we submit herewith the Investors' Presentation of the Company, with respect to Business Overview of Gujarat Themis Biosyn Limited ('the Company').Further, a copy of the same is also available on the website of the Company, viz., www.gtbl.in",
            "news_id": "88af195b-9a34-4b8e-a531-e6e3ad8e6d02",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a60851d2-908e-41e5-a393-b590da4f9eab.pdf",
            "news_date": "2023-05-15 09:36:14",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results -Financial Results For March 31, 2023.",
            "news_body": "The Board of Directors at its meeting held today, considered and approved the following matters:<BR> <BR> 1. Approved the Audited Financial Results for the Quarter and Year ended 31st March, 2023. <BR> <BR> A copy of Audited Financial Results for the Quarter and Year ended 31st March, 2023 is enclosed herewith. (Annexure I).<BR> <BR> 2. Appointed CS Ketan R. Shirwadkar (ACS 37829) or failing him, CS Prakash Nagringrekar (ACS 5941), Designated Partners of HSPN & Associates LLP, Practicing Company Secretary, Mumbai, as the Scrutinizer for conducting E-Voting and Polling at the 42nd Annual General Meeting.<BR> <BR> 3. Recommended dividend for Financial Year ended 31.03.2023 of Rs.1/- i.e. @ 20% per equity share having face value of Rs.5/- , aggregating to Rs. 1,45,28,702. The payment is subject to the approval of shareholders at the ensuing AGM <BR> <BR> 4. Considered the appointment of M/s. RAJA DUTTA & CO., Cost Accountant as the Cost Auditors of the Company.<BR>",
            "news_id": "859116ef-b271-4b4d-a035-097c5dcf4be1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9696a74-13a4-422a-8c79-d58efd953ac4.pdf",
            "news_date": "2023-05-13 13:51:38",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Under Reg. 30 Of SEBI (LODR) Regulations, 2015",
            "news_body": "The Board of Directors at its meeting held today, considered and approved the following matters:<BR> <BR> 1. Approved the Audited Financial Results for the Quarter and Year ended 31st March, 2023. <BR> <BR> A copy of Audited Financial Results for the Quarter and Year ended 31st March, 2023 is enclosed herewith. (Annexure I).<BR> <BR> 2. Appointed CS Ketan R. Shirwadkar (ACS 37829) or failing him, CS Prakash Nagringrekar (ACS 5941), Designated Partners of HSPN & Associates LLP, Practicing Company Secretary, Mumbai, as the Scrutinizer for conducting E-Voting and Polling at the 42nd Annual General Meeting.<BR> <BR> 3. Recommended dividend for Financial Year ended 31.03.2023 of Rs.1/- i.e. @ 20% per equity share having face value of Rs.5/- , aggregating to Rs. 1,45,28,702. The payment is subject to the approval of shareholders at the ensuing AGM <BR> <BR> 4. Considered the appointment of M/s. RAJA DUTTA & CO., Cost Accountant as the Cost Auditors of the Company.<BR>",
            "news_id": "97882dbd-b7bd-4253-8f8c-1ca2e76a02c2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=60178ed7-d63f-43a2-b4ae-f376fe7f893e.pdf",
            "news_date": "2023-05-13 13:43:00",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and with reference to our letter dated 31st January, 2023, intimating you about the earning conference call for Q3 & 9M FY23 with Analysts/Investors held on 6th February, 2023, please find attached herewith the transcript of the aforesaid conference call.The above information is also available on the website of the Company at www.gtbl.in Kindly take the same on record.",
            "news_id": "ff626618-3872-471a-8612-8203c96913bb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b32ae0b-ab9c-40ef-bbc4-2b192222f44b.pdf",
            "news_date": "2023-02-09 17:36:38",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of The Earnings Conference Call For Q3 &9M FY23",
            "news_body": "Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that the audio recording of earnings conference call, conducted on February 6, 2023, for the quarter ended December 31, 2022, has been uploaded on the website of the Company at  http://www.gtbl.in/wp-content/uploads/2023/02/Concall-Gujarat-Themis-Biosyn-Limited-06-02-2023.mp3",
            "news_id": "5e245272-9218-46d1-a55e-80b51050f114",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=147943ec-8072-4d25-8c09-6f76287f45ca.pdf",
            "news_date": "2023-02-06 19:35:06",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we submit herewith the Investors' Presentation of the Company, with respect to Business Overview of Gujarat Themis Biosyn Limited ('the Company').Further, a copy of the same is also available on the website of the Company, viz., www.gtbl.in",
            "news_id": "cd61c46a-3038-4bcc-b266-e50c32082405",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48abc818-2db0-411e-b181-4314beabe7d8.pdf",
            "news_date": "2023-02-06 12:23:59",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results -Financial Results For December 31, 2022 (Quarterly)",
            "news_body": "The Board of Directors at its meeting held today, considered and approved the Unaudited Financial Results of the Company for the Quarter ended 31st December, 2022.   A copy of Unaudited Financial Results of the Company for the Quarter ended 31st December, 2022 together with Limited Review Report is enclosed herewith.This may be taken as compliance under the Listing Regulations.",
            "news_id": "997a1db0-2116-4936-bb56-1cb697192242",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5ed8200-c8e0-4128-9041-1a2a583b773a.pdf",
            "news_date": "2023-02-03 11:11:24",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transaction As On September 30, 2022",
            "news_body": "Related PartyPursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of Related Party Transactions on a Standalone basis for the half year ended 30th September, 2022.Kindly take the same on your records. Transaction as on September 30, 2022",
            "news_id": "e5df9b5c-eaf0-4284-a571-9834f7a8a252",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8ccee73-b7dc-4759-b9e5-1da2e7518ca0.pdf",
            "news_date": "2022-11-21 21:16:19",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and with reference to our letter dated 7th November, 2022, intimating you about the earning conference call for Q2 & H1 FY23 with Analysts/Investors held on 16th November, 2022, please find attached herewith the transcript of the aforesaid conference call.The above information is also available on the website of the Company at www.gtbl.in",
            "news_id": "75124d3d-82dc-4484-9dfb-452dbcd87713",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bb57963-fa06-4f09-9304-e4c994e2183b.pdf",
            "news_date": "2022-11-21 13:58:29",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of The Maiden Earnings Conference Call For Q2 & H1 FY23 Held On 16.11.2022",
            "news_body": "Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that the audio recording of earnings conference call, conducted on November 16, 2022, for the quarter ended September 30, 2022, has been uploaded on the website of the Company at viz., www.gtbl.in",
            "news_id": "50f1fac3-d2c9-4099-b278-34a30e900bc6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0f7571d-f22d-4496-807d-accb24d2d917.pdf",
            "news_date": "2022-11-16 18:34:42",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we submit herewith the Investors' Presentation of the Company, with respect to Business Overview of Gujarat Themis Biosyn Limited ('the Company').Further, a copy of the same is also available on the website of the Company, viz., www.gtbl.in",
            "news_id": "49089f58-9d36-4c26-b2aa-a8602a0b2274",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7384bc66-029d-4891-a3ea-107d21874b71.pdf",
            "news_date": "2022-11-09 22:27:40",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Result For September 30, 2022(Half Yearly)",
            "news_body": "The Board of Directors at its meeting held today, considered and approved the Unaudited Financial Results of the Company for the Quarter / Half year ended 30th September, 2022.   <BR> <BR> A copy of Unaudited Financial Results of the Company for the Quarter / Half year ended 30th September, 2022 together with Limited Review Report is enclosed herewith.<BR> <BR> This may be taken as compliance under the Listing Regulations.<BR> <BR> Kindly take the same on record.<BR>",
            "news_id": "5546e89b-f807-4f58-9e04-9604abd2b2dd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fde407d0-ffd1-46a1-be2d-b6b51b82ea72.pdf",
            "news_date": "2022-11-07 12:08:29",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 07.11.2022 Under Reg. 30 Of SEBI (LODR) Regulations, 2015",
            "news_body": "The Board of Directors at its meeting held today, considered and approved the Unaudited Financial Results of the Company for the Quarter / Half year ended 30th September, 2022.   <BR> <BR> A copy of Unaudited Financial Results of the Company for the Quarter / Half year ended 30th September, 2022 together with Limited Review Report is enclosed herewith.<BR> <BR> This may be taken as compliance under the Listing Regulations.<BR> <BR> Kindly take the same on record.<BR>",
            "news_id": "0d65142c-96e6-40d7-b2f0-26cf929f4204",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=920fcaa8-e118-44ca-b3bf-0292beead1ad.pdf",
            "news_date": "2022-11-07 12:03:25",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we submit herewith the Investors' Presentation of the Company, with respect to Business Overview of Gujarat Themis Biosyn Limited ('the Company').Further, a copy of the same is also available on the website of the Company, viz., www.gtbl.in",
            "news_id": "42ba367b-a8bc-4e71-a88c-1455274f4f1e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eade8287-0280-4d0d-9845-e648f317724f.pdf",
            "news_date": "2022-06-09 11:05:39",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For March 31, 2022(Yearly)",
            "news_body": "1. Approved the Audited Financial Results for the Quarter and Year ended 31st March, 2022. <BR> <BR> A copy of Audited Financial Results for the Quarter and Year ended 31st March, 2022 is enclosed herewith. ( Annexure I).<BR> <BR> 2. Appointed CS Ketan R. Shirwadkar (ACS 37829) or failing him, CS Prakash Nagringrekar (ACS 5941), Designated Partners of HSPN & Associates LLP, Practicing Company Secretary, Mumbai, as the Scrutinizer for conducting E-Voting and Polling at the 41st Annual General Meeting.<BR> <BR> 3. Recommended dividend for Financial Year ended 31.03.2022 of Rs.4.00/- i.e. @ 80% per equity share having face value of Rs.5/-, aggregating to Rs. 5.81 Crores. The payment is subject to the approval of shareholders at the ensuing AGM <BR> <BR> 4. Considered the appointment of M/s. RAJA DUTTA & CO., Cost Accountant as the Cost Auditors of the Company.<BR>",
            "news_id": "57cef813-4654-4cd5-9235-b5fea87a7255",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1baf6411-22f8-4b6a-96a1-39eddac6b01d.pdf",
            "news_date": "2022-05-20 12:46:07",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Under Reg. 30 Of SEBI (LODR) Regulations, 2015.",
            "news_body": "The Board of Directors at its meeting held today, considered and approved the following matters:<BR> <BR> 1. Approved the Audited Financial Results for the Quarter and Year ended 31st March, 2022. <BR> <BR> A copy of Audited Financial Results for the Quarter and Year ended 31st March, 2022 is enclosed herewith. ( Annexure I).<BR> <BR> 2. Appointed CS Ketan R. Shirwadkar (ACS 37829) or failing him, CS Prakash Nagringrekar (ACS 5941), Designated Partners of HSPN & Associates LLP, Practicing Company Secretary, Mumbai, as the Scrutinizer for conducting E-Voting and Polling at the 41st Annual General Meeting.<BR> <BR> 3. Recommended dividend for Financial Year ended 31.03.2022 of Rs.4.00/- i.e. @ 80% per equity share having face value of Rs.5/-, aggregating to Rs. 5.81 Crores. The payment is subject to the approval of shareholders at the ensuing AGM <BR> <BR> 4. Considered the appointment of M/s. RAJA DUTTA & CO., Cost Accountant as the Cost Auditors of the Company.",
            "news_id": "dbbaf49d-1d89-4369-b3e3-3e61c9e8fe61",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0d9a98a8-ad42-4fcd-8d0a-8786e71d8a1f.pdf",
            "news_date": "2022-05-20 12:41:59",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results -Financial Results For December 31, 2021.(Quarterly)",
            "news_body": "Meeting Commencement Time  : 10:00 A.M<BR> Meeting Conclusion Time   : 11:30 A.M<BR> <BR> The Board of Directors at its meeting held today, considered and approved the following matters:<BR> <BR> 1. Unaudited Financial Results of the Company for the Quarter and Nine months ended 31st December, 2021.  <BR> <BR> A copy of Unaudited Financial Results of the Company for the Quarter & Nine months ended 31st December, 2021 together with Limited Review Report is enclosed herewith.<BR> <BR> 2. Appointed M/s. HSPN & ASSOCIATES LLP., Practicing Company Secretary as Secretarial Auditor for the purpose of conducting Secretarial Audit for the financial year 2021-22<BR> <BR> This may be taken as compliance under the Listing Regulations.<BR>",
            "news_id": "53a00036-dbae-4962-865c-0112ec411f44",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4017fa7e-0f3a-4726-b02e-4f317c68c180.pdf",
            "news_date": "2022-02-11 11:40:10",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 11.02.2022 Under Reg. 30 Of SEBI (LODR) Regulations, 2015",
            "news_body": "Meeting Commencement Time  : 10:00 A.M<BR> Meeting Conclusion Time   : 11:30 A.M<BR> <BR> The Board of Directors at its meeting held today, considered and approved the following matters:<BR> <BR> 1. Unaudited Financial Results of the Company for the Quarter and Nine months ended 31st December, 2021.  <BR> <BR> A copy of Unaudited Financial Results of the Company for the Quarter & Nine months ended 31st December, 2021 together with Limited Review Report is enclosed herewith.<BR> <BR> 2. Appointed M/s. HSPN & ASSOCIATES LLP., Practicing Company Secretary as Secretarial Auditor for the purpose of conducting Secretarial Audit for the financial year 2021-22<BR>",
            "news_id": "23597b42-f3b2-41fa-9e40-4ceb318d3ee0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d475ac2-6dac-4c93-956b-0a82e04f619d.pdf",
            "news_date": "2022-02-11 11:37:00",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "This has reference to our intimation bearing ref GTBL: CS: BSE-CORR/2021-22 dated 18th November, 2021. The first page of transcript details of Management the Company name -Gujarat Themis Biosyn Limited has been inadvertently appeared after the name of Mr. Tushar Dalal and Mr. Sangameshwar Iyer and Compliance Officer after Mr. Sangameshwar Iyer.<BR> <BR> We have therefore rectified the typographical error and no change except the first page.<BR> <BR> Hence, we are enclosing herewith the Earnings Call Transcript pertaining to 02 and H1 of FY22 Financial Results of the Company with the rectified first page.<BR> <BR> The aforesaid information is also being made available on the website of the Company at www.gtbl.in.<BR> <BR> Kindly take the same on record.<BR>",
            "news_id": "9032aeef-329f-45ba-9748-74064fc6f7fa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d3dd59e-7118-4fc5-b989-2fd139f2d0af.pdf",
            "news_date": "2021-11-19 21:34:44",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to our letter dated November 8, 2021, and pursuant to Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Earnings Call Transcript pertaining to 02 and H1 of FY22 Financial Results of the Company.<BR> <BR> The aforesaid information is also being made available on the website of the Company at www.gtbl.in.<BR>",
            "news_id": "6288cb47-d950-4f3d-8839-cc0108f862ea",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5cbf9dd-1f15-42e9-a0af-7efd35b31489.pdf",
            "news_date": "2021-11-18 18:13:59",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we submit herewith the Investors' Presentation of the Company, with respect to Business Overview of Gujarat Themis Biosyn Limited ('the Company').<BR> <BR> Further, a copy of the same is also available on the website of the Company, viz., www.gtbl.in<BR> <BR> Thanking you,<BR> Yours faithfully,<BR>",
            "news_id": "7ebdd5f5-0f63-40ba-a39a-d5d52dab6a15",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c60e1f01-d520-4585-aa58-2cb1f1147d99.pdf",
            "news_date": "2021-11-15 17:36:24",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For September 30,2021(Quarter And Half Year Ended)",
            "news_body": "The Board of Directors at its meeting held today, <BR> <BR> considered  and approved the following matters:<BR> <BR> 1. Un-Audited Financial Results for the Quarter and Half Year ended 30th September, 2021.<BR> <BR> A copy at Unaudited Financial Results at the Company for the Quarter ended 30th September, 2021 together with Limited Review Report is enclosed herewith<BR> <BR> 2. Declaration of an Interim dividend for Financial Year 2021-2022 of Rs.7/-(Rs. 2 plus an additional Rs.5 on the completion of forty years of establishment of the Company) (Rupee Seven only.) per equity share having face value of Rs.5/-, i.e. 140% aggregating to Rs. 10.17 Crore.<BR> <BR> 3. The Record Date for the same is November 18, 2021.<BR> <BR> 4. We are also attaching the Financials Highlights.<BR> <BR> This may be taken as compliance under the Listing Regulations.<BR>",
            "news_id": "53a9842d-8e88-4384-a161-9f238e419288",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4155bd4-aac6-4322-96fc-d5c78b3f2796.pdf",
            "news_date": "2021-11-11 13:54:13",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting For The Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2021",
            "news_body": "The Board of Directors at its meeting held today, <BR> <BR> considered  and approved the following matters:<BR> <BR> 1. Un-Audited Financial Results for the Quarter and Half Year ended 30th September, 2021.<BR> <BR> A copy at Unaudited Financial Results at the Company for the Quarter ended 30th September, 2021 together with Limited Review Report is enclosed herewith<BR> <BR> 2. Declaration of an Interim dividend for Financial Year 2021-2022 of Rs.7/-(Rs. 2 plus an additional Rs.5 on the completion of forty years of establishment of the Company) (Rupee Seven only.) per equity share having face value of Rs.5/-, i.e. 140% aggregating to Rs. 10.17 Crore.<BR> <BR> 3. The Record Date for the same is November 18, 2021.<BR> <BR> 4. We are also attaching the Financials Highlights.<BR> <BR> This may be taken as compliance under the Listing Regulations.<BR>",
            "news_id": "4962b044-a333-4ffb-a7a7-4734b8f1d951",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8c18c3f-ae14-406e-b568-a4310fa88843.pdf",
            "news_date": "2021-11-11 13:50:58",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we submit herewith the Investors' Presentation of the Company, with respect to Business Overview of Gujarat Themis Biosyn Limited ('the Company').<BR> <BR> Further, a copy of the same is also available on the website of the Company, viz., www.gtbl.in",
            "news_id": "0c0fda8e-97ba-42c6-a41a-3ea3d22bcfc2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c9def75-ea89-4636-b37e-532705874176.pdf",
            "news_date": "2021-09-13 12:22:19",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financials Results For June, 30, 2021(Quarterly)",
            "news_body": "The Board of Directors at its meeting held today, considered and approved the following matters:<BR> <BR> 1. Unaudited Financial Results of the Company for the Quarter ended 30thJune, 2021.<BR> <BR> A copy of Unaudited Financial Results of the Company for the Quarter ended 30th June, 2021 together with Limited Review Report is enclosed herewith.<BR>",
            "news_id": "2fb7f01b-50a1-4f8c-8a86-659533972828",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb3a3512-b2d5-4faa-b5e1-df070b360eff.pdf",
            "news_date": "2021-08-12 12:38:34",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Under Reg. 30 Of SEBI (LODR) Regulations, 2015",
            "news_body": "The Board of Directors at its meeting held today, considered and approved the following matters:<BR> <BR> 1. Unaudited Financial Results of the Company for the Quarter ended 30thJune, 2021.<BR> <BR> A copy of Unaudited Financial Results of the Company for the Quarter ended 30th June, 2021 together with Limited Review Report is enclosed herewith.<BR> <BR> 2. Confirmed the time, and date of the 40th Annual General Meeting which will be held on Friday, 17th September, 2021 at 12:00 Noon.<BR> <BR> 3. Closure of Register of Members and Share Transfer Books from 11thSeptember, 2021 to 17th  September, 2021 for the purpose of 40th  Annual General Meeting.",
            "news_id": "de649052-5627-4fdf-a7f5-aaaea0f85943",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf555abe-ac1f-4f52-9d3e-bb749df70410.pdf",
            "news_date": "2021-08-12 12:34:13",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the disclosure of Related Party Transactions, in the format specified in the accounting standards for the half year ended March 31, 2021.<BR> <BR> This communication is in compliance with the captioned subject and for your information and record.<BR>",
            "news_id": "58751936-d9bd-4200-bbe3-4dc913acedd7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7c71e12-e07b-42dd-a49a-63dbd07bcae3.pdf",
            "news_date": "2021-05-21 19:30:39",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "GUJTHEM",
            "disp": "Gujarat Themis Biosyn",
            "bse_code": 506879,
            "isin": "INE942C01045",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Year Ended 31/03/2021",
            "news_body": "The Board of Directors at its meeting held today, transacted/ approved the following matters:<BR> <BR> 1. Approved the Audited Financial Results for the Quarter and Year ended 31.03 2021.<BR> 2. Appointment of Ms. Kirandeep Madan (DIN: 00686547) as an Additional Independent Woman Director.<BR> 3. Noting of resignation of Mr. Parag Bodha as Company Secretary and Compliance Officer from close of working hours on 11.05.2021.<BR> 4. Appointment of Mr. Rahul Soni (ACS 61305) as Company Secretary and Compliance Officer w.e.f. 12.05. 2021. <BR> 5. Appointed M/s. KRS& Co., Practising Company Secretaries as the Scrutinizer for conducting E-Voting and Polling at the 40th Annual General Meeting.<BR> 6. After taking into account, the uncertainties arising out of Covid-19, the Board of Directors has decided not to recommend any Dividend for the present.<BR>",
            "news_id": "ec90328c-817d-4e45-a7ff-f3355259a923",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7da96ea7-a0fe-439c-8de8-ebebfb725168.pdf",
            "news_date": "2021-05-01 14:01:35",
            "seo": "gujarat-themis-biosyn-ltd",
            "ltp": 330.35,
            "ch": -8.099999999999966,
            "pch": -2.3932634067070366,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 29731,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}